Candesartan vs Propranolol for Migraine Prevention: A Double Blind, Placebo Controlled, Double Dummy, Triple Cross-Over Study

Trial Profile

Candesartan vs Propranolol for Migraine Prevention: A Double Blind, Placebo Controlled, Double Dummy, Triple Cross-Over Study

Completed
Phase of Trial: Phase II/III

Latest Information Update: 23 Dec 2013

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Propranolol
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Jun 2013 Primary endpoint 'Days-with-headache' has been met according to results presented at the 2013 International Headache Congress.
    • 30 Jun 2013 Results presented at the 2013 International Headache Congress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top